Answers are grounded in this paper and cite their sources.
Ann Oncol 2011; 22(11): 1554–1560 (doi: 10.1093/annonc/mdq617) In the original article, Figure 4B was identical to Figure 4A. This has now been corrected online and appears below. Clinical relevance of TNM staging system according to breast cancer subtypesAnnals of OncologyVol. 22Issue 7PreviewThere has been reported that the association between nodal spread and tumor size was disrupted in triple-negative breast cancer (TNBC) and it showed characteristically early relapse. The TNM (tumor–node–metastasis) staging system might not be equally effective as a prognostic indicator for all subtypes. The aim of our study was to evaluate the usefulness of the staging according to subtypes.
No takes yet. Share an insight, caveat, or question.
Park et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: